Literature DB >> 12182498

Gender differences in morningness-eveningness preference.

Ana Adan1, Vincenzo Natale.   

Abstract

Morningness-eveningness preference (morning-, intermediate-, evening-type) or circadian typology is the individual difference that most clearly explains the variations in the rhythmic expression of biological or behavioral patterns. The aim of this study was to analyze gender difference in morningness-eveningness preference using the Horne and Ostberg questionnaire in the largest university student population selected so far (N = 2135), with an age range 18-30 yr. Morningness-eveningness questionnaire (MEQ) score distribution closely correlated to the normal curve (range 17-78, mean = 48.25; SD = 10.11), with 338 (15.84%) morning-types, 1273 (59.62%) intermediate-types, and 524 (24.54%) evening-types. The men and women differed significantly in their mean scores (p < 0.0001) and distribution per circadian typology (p < 0.00001), with the men presenting a more pronounced eveningness preference. Three factors were identified by factor analysis: time of greatest efficiency (I), sleep time/sleep phase (II), awakening time/sleep inertia (III). The MEQ items sensitive to gender differences were essentially those included in factor I and factor II. The results are discussed in relation to recent models of circadian regulation of the sleep-wake cycle.

Entities:  

Mesh:

Year:  2002        PMID: 12182498     DOI: 10.1081/cbi-120005390

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  90 in total

1.  Constraint is associated with earlier circadian phase and morningness: Confirmation of relationships between personality and circadian phase using a constant routine protocol.

Authors:  B Bullock; G Murray; J L Anderson; T Cooper-O'Neill; J J Gooley; S W Cain; S W Lockley
Journal:  Pers Individ Dif       Date:  2016-07-31

2.  Stress, geomagnetic disturbance, infradian and circadian sampling for circulating corticosterone and models of human depression?

Authors:  A Olah; R Jozsa; V Csernus; J Sandor; A Muller; M Zeman; W Hoogerwerf; G Cornélissen; F Halberg
Journal:  Neurotox Res       Date:  2008-04       Impact factor: 3.911

3.  Gonadal- and sex-chromosome-dependent sex differences in the circadian system.

Authors:  Dika A Kuljis; Dawn H Loh; Danny Truong; Andrew M Vosko; Margaret L Ong; Rebecca McClusky; Arthur P Arnold; Christopher S Colwell
Journal:  Endocrinology       Date:  2013-02-25       Impact factor: 4.736

Review 4.  Sex differences in circadian timing systems: implications for disease.

Authors:  Matthew Bailey; Rae Silver
Journal:  Front Neuroendocrinol       Date:  2013-11-25       Impact factor: 8.606

5.  Season of birth, gender, and social-cultural effects on sleep timing preferences in humans.

Authors:  Vincenzo Natale; Ana Adan; Marco Fabbri
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

6.  Chronotype and time-of-day influences on the alerting, orienting, and executive components of attention.

Authors:  Robert L Matchock; J Toby Mordkoff
Journal:  Exp Brain Res       Date:  2008-09-23       Impact factor: 1.972

7.  Genetics of Sleep Timing, Duration and Homeostasis in Humans.

Authors:  Namni Goel
Journal:  Sleep Med Clin       Date:  2011-06-03

Review 8.  Rhythms of life: circadian disruption and brain disorders across the lifespan.

Authors:  Ryan W Logan; Colleen A McClung
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

9.  Diurnal and circadian variation of sleep and alertness in men vs. naturally cycling women.

Authors:  Diane B Boivin; Ari Shechter; Philippe Boudreau; Esmot Ara Begum; Ng Mien Kwong Ng Ying-Kin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

10.  Reliability and validity of the Korean version of Morningness-Eveningness Questionnaire in adults aged 20-39 years.

Authors:  Jung Hie Lee; Seong Jae Kim; Se Yong Lee; Kwang Ho Jang; In Soo Kim; Jeanne F Duffy
Journal:  Chronobiol Int       Date:  2014-01-27       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.